Citations

Clear

750 citation(s) found for "Lowe, Val J".

P3‐010: MULTIPLE SCLEROSIS MASQUERADING AS ALZHEIMER'S TYPE DEMENTIA: CLINICAL, RADIOLOGICAL, AND PATHOLOGICAL FINDINGS
Popescu, Bogdan , Lowe, Val J. , Pirko, Istvan, Fields, Julie A. , Lucchinetti, Claudia F. , Tobin, W. Oliver , Kantarci, Kejal , Boeve, Bradley F.

Mayo Clinic

Alzheimer's & Dementia | September 6, 2014 | Volume: 10 | Issue: 4S_Part_17 | Pages: No page available

10.1016/j.jalz.2014.05.1097 Get It

O3‐10‐03: SEX AND APOE EFFECTS ON MEMORY PERFORMANCE, NEURODEGENERATION, AND B‐AMYLOID ACROSS THE ADULT LIFESPAN
Wiste, Heather J. , Weigand, Stephen D. , Lowe, Val J. , Gunter, Jeffrey L. , Gregg, Brian E., Rocca, Walter A. , Petersen, Ronald C. , Jack, Clifford R. , Knopman, David S. , Vemuri, Prashanthi , Mielke, Michelle M. , Senjem, Matthew L. , Machulda, Mary M. , Pankratz, V. Shane

Mayo Clinic

Alzheimer's & Dementia | September 6, 2014 | Volume: 10 | Issue: 4S_Part_3 | Pages: No page available

10.1016/j.jalz.2014.04.325 Get It

P1‐240: ENHANCED BRAIN‐UPTAKE OF C11‐PIB IN A MOUSE MODEL OF ALZHEIMER'S DISEASE VIA A SYNTHETIC PEPTIDE CARRIER
Lowe, Val J. , Curran, Geoffry L., Decklever, Teresa, Schmeichel, Ann M., Jenkins, Robert B. , Sarkar, Gobinda

Mayo Clinic

Alzheimer's & Dementia | September 6, 2014 | Volume: 10 | Issue: 4S_Part_10 | Pages: No page available

10.1016/j.jalz.2014.05.479 Get It

O3‐03‐05: LONGITUDINAL MRI AND NEUROPSYCHOLOGICAL CHANGES IN SYMPTOMATIC FRONTOTEMPORAL LOBAR DEGENERATION SUBJECTS WITH MUTATIONS IN MAPT, PGRN, AND C9ORF72
Graff‐Radford, Jonathan, Weigand, Stephen D. , Przybelski, Scott A. , Whitwell, Jennifer , Graff‐Radford, Neill R. , Josephs, Keith A. , Fields, Julie A. , Lucas, John A. , Lowe, Val J. , Gavrilova, Ralitza H. , Kuntz, Karen M. , Hernandez, Mariely DeJesus, Rademakers, Rosa , Petersen, Ronald C. , Graff‐Radford, Jonathan , Jones, David T. , Senjem, Matthew L. , Knopman, David S. , Wszołek, Zbigniew K. , Vemuri, Prashanthi , Ferman, Tanis J. , Baker, Matthew , Kantarci, Kejal , Jack, Clifford R. , Boeve, Bradley F.

Mayo Clinic

Alzheimer's & Dementia | September 6, 2014 | Volume: 10 | Issue: 4S_Part_3 | Pages: No page available

10.1016/j.jalz.2014.04.284 Get It

O4‐06‐06: APATHY AND REDUCED STRIATAL UPTAKE IN DEMENTIA WITH LEWY BODIES
Graff‐Radford, Jonathan, Lowe, Val J. , Peller, Patrick J., Przybelski, Scott A. , Bennett, Jamie, Aakre, Jeremiah A. , Knopman, David S. , Petersen, Ronald C. , Graff‐Radford, Jonathan , Kantarci, Kejal , Jones, David T. , Ferman, Tanis J. , Smith, Glenn E. , Pankratz, V. Shane , Knopman, David S. , Boeve, Bradley F.

Mayo Clinic

Alzheimer's & Dementia | September 6, 2014 | Volume: 10 | Issue: 4S_Part_4 | Pages: No page available

10.1016/j.jalz.2014.04.420 Get It

IC‐P‐136: APATHY AND REDUCED STRIATAL UPTAKE IN DEMENTIA WITH LEWY BODIES
Graff‐Radford, Jonathan, Lowe, Val J. , Jones, David, Peller, Patrick J., Przybelski, Scott A. , Bennett, Jamie, Aakre, Jeremiah A. , Petersen, Ronald C. , Graff‐Radford, Jonathan , Kantarci, Kejal , Ferman, Tanis J. , Smith, Glenn E. , Pankratz, V. Shane , Knopman, David S. , Boeve, Bradley F.

Mayo Clinic

Alzheimer's & Dementia | September 6, 2014 | Volume: 10 | Issue: 4S_Part_7 | Pages: No page available

10.1016/j.jalz.2014.05.142 Get It

P2‐388: ELIGIBILITY FOR AN EXERCISE STUDY IN ASYMPTOMATIC PRE‐ALZHEIMER'S DISEASE
Haley, Dana , Parfitt, Francine, Fletcher, Barbara J., Fletcher, Gerald F., Jain, Manoj , Lowe, Val J. , Vemuri, Prashanthi R., Diehl, Nancy N. , Graff‐Radford, Neill R. , Jack, Clifford R. , Vemuri, Prashanthi , Crook, Julia E.

Mayo Clinic

Alzheimer's & Dementia | September 6, 2014 | Volume: 10 | Issue: 4S_Part_17 | Pages: No page available

10.1016/j.jalz.2014.05.1068 Get It

Salvage Lymph Node Dissection for Prostate Cancer Nodal Recurrence Detected by 11 C-Choline Positron Emission Tomography/Computerized Tomography
Karnes, R. Jeffrey , Bergstralh, Eric J., Dimonte, Guy , Cheville, John C. , Lowe, Val J. , Mynderse, Lance A. , Kwon, Eugene D., Murphy, Christopher R, Murphy, Christopher Raymond

Mayo Clinic

Journal of Urology | August 20, 2014 | Volume: 193 | Issue: 1 | Pages: 111-116

10.1016/j.juro.2014.08.082 | PMID 25150640 Get It

Dementia with Lewy bodies
Graff‐Radford, Jonathan , Murray, Melissa E. , Lowe, Val J. , Ferman, Tanis J. , Przybelski, Scott A. , Lesnick, Timothy G. , Senjem, Matthew L. , Gunter, Jeffrey L. , Smith, Glenn E. , Petersen, Ronald C. , Kantarci, Kejal , Boeve, Bradley F. , Knopman, David S. , Jack, Clifford R. , Dickson, Dennis W. , Senjem, Matthew L , Kantarci, Kejal , Murray, Melissa E , Ferman, Tanis J

Mayo Clinic

Neurology | July 24, 2014 | Volume: 83 | Issue: 9 | Pages: 801-809

10.1212/wnl.0000000000000734 | PMID 25056580 Get It

APOE ε4 influences β‐amyloid deposition in primary progressive aphasia and speech apraxia
Josephs, Keith A. , Senjem, Matthew L. , Lowe, Val J. , Whitwell, Jennifer L. , Strand, Edythe A. , Duffy, Joseph R. , Machulda, Mary M. , Jack, Clifford R. , Senjem, Matthew L

Mayo Clinic

Alzheimer's & Dementia | June 28, 2014 | Volume: 10 | Issue: 6 | Pages: 630-636

10.1016/j.jalz.2014.03.004 | PMID 24985533 Get It

AbstractBackgroundApolipoprotein E ε4 (APOE ε4) is a risk factor for β‐amyloid deposition in Alzheimer's disease dementia. Its influence on β‐amyloid deposition in speech and language disorders, including primary progressive aphasia (PPA), is unclear.MethodsOne hundred thirty subjects with PPA or progressive speech apraxia underwent APOE genotyping and Pittsburgh compound B (PiB) PET scanning. The relationship between APOE ε4 and PiB status, as well as severity and regional distribution of PiB, was assessed.ResultsForty‐five subjects had an APOE ε4 allele and 60 subjects were PiB‐positive. The odds ratio for a subject with APOE ε4 being PiB‐positive compared with a subject without APOE ε4 being PiB‐positive was 10.2 (95% confidence interval, 4.4–25.5; P < .0001). The APOE ε4 allele did not influence regional PiB distribution or severity.ConclusionAPOE ε4 increases the risk of β‐amyloid deposition in PPA and progressive speech apraxia but does not influence regional β‐amyloid distribution or severity.